Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Poppe

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
JIMD Reports|February 23, 2013
Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERTW Terryn, R Vanholder, D Hemelsoet, et al.
Leukemia|April 16, 2004
Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic featuresM Stevens-Kroef, B Poppe, S van Zelderen-Bhola, et al.
Leukemia|January 12, 2017
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemiaS Peirs, V Frismantas, F Matthijssens, et al.
British Journal of Cancer|March 15, 2012
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer familiesD J Osher, K De Leeneer, G Michils, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillanceS Laurent, D Franchimont, J P Coppens, et al.
Leukemia|May 12, 2016
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemiaA Wallaert, K Durinck, W Van Loocke, et al.
Leukemia|June 26, 2015
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemiaK Durinck, W Van Loocke, J Van der Meulen, et al.
BMC Cancer|November 19, 2015
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancerF Z Francies, T Wainstein, K De Leeneer, et al.
Leukemia|January 28, 2005
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemiasF Speleman, B Cauwelier, N Dastugue, et al.
Leukemia|September 19, 2014
MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemiaE Mets, J Van der Meulen, G Van Peer, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
JIMD Reports|February 23, 2013
Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERTW Terryn, R Vanholder, D Hemelsoet, et al.
Leukemia|April 16, 2004
Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic featuresM Stevens-Kroef, B Poppe, S van Zelderen-Bhola, et al.
Leukemia|January 12, 2017
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemiaS Peirs, V Frismantas, F Matthijssens, et al.
British Journal of Cancer|March 15, 2012
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer familiesD J Osher, K De Leeneer, G Michils, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillanceS Laurent, D Franchimont, J P Coppens, et al.
Leukemia|May 12, 2016
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemiaA Wallaert, K Durinck, W Van Loocke, et al.
Leukemia|June 26, 2015
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemiaK Durinck, W Van Loocke, J Van der Meulen, et al.
BMC Cancer|November 19, 2015
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancerF Z Francies, T Wainstein, K De Leeneer, et al.
Leukemia|January 28, 2005
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemiasF Speleman, B Cauwelier, N Dastugue, et al.
Leukemia|September 19, 2014
MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemiaE Mets, J Van der Meulen, G Van Peer, et al.
Pageof 11